Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 8, 2014

View Archived Issues

The discovery of a new protein target and novel compounds for the treatment of malaria

Receptos initiates phase III portion of RADIANCE trial of RPC-1063 for relapsing MS

Capricor and Janssen enter collaboration to develop cell therapies for cardiovascular applications

Cytomedix completes enrollment in RECOVER-Stroke trial of ALD-401 in cerebral ischemic stroke

Cellceutix files application to commence trials of anti-psoriasis drug Prurisol

RedHill Biopharma reports pharmacokinetic results for RHB-104

GS-9973 demonstrates promising activity in phase II trial

Vaccination with ImMucin leads to promising clinical response in phase I/II trials

High-throughput screening based on physiological function for novel indications of existing drugs

Horizon Discovery forms oncology agreement with AstraZeneca

Cenicriviroc, a dual CCR2/CCR5 inhibitor, as novel therapeutic strategy for liver fibrosis

Catalyst Pharmaceutical completes type B meeting with FDA for Firdapse

Generex Biotechnology confirms database lock for AE-37 breast cancer vaccine trial

ST-10 meets endpoints in phase III AEGIS trial for iron deficiency anemia in IBD

Cytovir ADV ready to receive orphan drug designation in Europe

e-Therapeutics provides update on phase I ETS-2101 trial

Ossianix forms research collaboration with Lundbeck

Committee recommends stopping Imbruvica study based on significant survival improvement

Abraxane plus gemcitabine receives European approval for metastatic pancreatic cancer

Orexigen Therapeutics receives new FDA action date for Contrave

Sutro Biopharma and Memorial Sloan-Kettering to produce antibodies for neuroblastoma

Qiagen launches therascreen IDH1/2 test for gliomas and collaborates with Mayo Clinic

Allergan and Medytox close licensing agreement covering neurotoxin product candidates

FDA grants orphan drug status to Alitair's Erdosteine in bronchiectasis

Japanese investigators patent novel OX1/OX2 receptor antagonists

Scil Proteins discloses new fusion proteins for cancer

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...